119 related articles for article (PubMed ID: 30393117)
21. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.
Braun CJ; Zhang X; Savelyeva I; Wolff S; Moll UM; Schepeler T; Ørntoft TF; Andersen CL; Dobbelstein M
Cancer Res; 2008 Dec; 68(24):10094-104. PubMed ID: 19074875
[TBL] [Abstract][Full Text] [Related]
22. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
23. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
24. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
[TBL] [Abstract][Full Text] [Related]
25. microRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway.
Ma Q; Wang X; Li Z; Li B; Ma F; Peng L; Zhang Y; Xu A; Jiang B
Oncol Rep; 2013 Apr; 29(4):1652-8. PubMed ID: 23380758
[TBL] [Abstract][Full Text] [Related]
26.
Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT
Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727
[TBL] [Abstract][Full Text] [Related]
27. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
[TBL] [Abstract][Full Text] [Related]
28. Post-transcriptional regulation of the tumor suppressor p53 by a novel miR-27a, with implications during hypoxia and tumorigenesis.
Maqbool R; Lone SN; Ul Hussain M
Biochem J; 2016 Oct; 473(20):3597-3610. PubMed ID: 27531966
[TBL] [Abstract][Full Text] [Related]
29. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation.
Cao B; Wang K; Liao JM; Zhou X; Liao P; Zeng SX; He M; Chen L; He Y; Li W; Lu H
Elife; 2016 Jul; 5():. PubMed ID: 27383270
[TBL] [Abstract][Full Text] [Related]
31. A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer.
Zhang R; Liu R; Liu C; Niu Y; Zhang J; Guo B; Zhang CY; Li J; Yang J; Chen X
Cell Physiol Biochem; 2017; 42(4):1559-1574. PubMed ID: 28738328
[TBL] [Abstract][Full Text] [Related]
32. miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1.
Li W; Chen A; Xiong L; Chen T; Tao F; Lu Y; He Q; Zhao L; Ou R; Xu Y
Tumour Biol; 2017 May; 39(5):1010428317698389. PubMed ID: 28466778
[TBL] [Abstract][Full Text] [Related]
33. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
34. CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.
He X; Kong X; Yan J; Yan J; Zhang Y; Wu Q; Chang Y; Shang H; Dou Q; Song Y; Liu F
Tumour Biol; 2015 Mar; 36(3):1437-44. PubMed ID: 25663456
[TBL] [Abstract][Full Text] [Related]
35. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
37. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development.
Su WJ; Fang JS; Cheng F; Liu C; Zhou F; Zhang J
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1720-5. PubMed ID: 23319651
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
39. miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells.
Morimoto Y; Mizushima T; Wu X; Okuzaki D; Yokoyama Y; Inoue A; Hata T; Hirose H; Qian Y; Wang J; Miyoshi N; Takahashi H; Haraguchi N; Matsuda C; Doki Y; Mori M; Yamamoto H
Br J Cancer; 2020 Mar; 122(7):1037-1049. PubMed ID: 32066912
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
Wang Y; Wu M; Lei Z; Huang M; Li Z; Wang L; Cao Q; Han D; Chang Y; Chen Y; Liu X; Xue L; Mao X; Geng J; Chen Y; Dai T; Ren L; Wang Q; Yu H; Chen C; Chu X
J Exp Clin Cancer Res; 2018 Nov; 37(1):292. PubMed ID: 30486864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
